Samenvatting van de aanvraag

Dit item is dichtgeklapt
Dit item is opengeklapt

The aim of the present study is to treat patients with Crohn’s disease refractory or intolerant to standard therapy with intensive myelo and immunosuppression using cyclofosfamide and alemtuzumab followed by autologous stem cell transplantation. It is hypothesized that this therapy will induce long-lasting remissions in patients with Crohn’s disease.

Naar boven
Direct naar: InhoudDirect naar: NavigatieDirect naar: Onderkant website